Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
4.790
+0.050 (1.05%)
At close: Dec 5, 2025, 4:00 PM EST
4.880
+0.090 (1.88%)
After-hours: Dec 5, 2025, 5:42 PM EST

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $157.67 million as of December 5, 2025. Its market cap has increased by 37.23% in one year.

Market Cap
157.67M
Enterprise Value
141.86M
1-Year Change
37.23%
Ranking
Category
Stock Price
$4.79

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $157.67M, an increase of 89.51%. That is a compound annual growth rate of 2.40%.

History

DateMarket Cap% Change
Nov 20, 2025144.80M93.84%
Dec 31, 202474.70M-38.06%
Dec 29, 2023120.60M-7.44%
Dec 30, 2022130.30M46.40%
Dec 31, 202189.00M21.92%
Dec 31, 202073.00M10.11%
Dec 31, 201966.30M-10.04%
Dec 31, 201873.70M106.44%
Dec 29, 201735.70M-24.52%
Dec 30, 201647.30M79.85%
Dec 31, 201526.30M10.04%
Dec 31, 201423.90M-39.34%
Dec 31, 201339.40M18.32%
Dec 31, 201233.30M73.44%
Dec 30, 201119.20M-39.81%
Dec 31, 201031.90M-65.14%
Dec 31, 200991.50M61.95%
Dec 31, 200856.50M-63.00%
Dec 31, 2007152.70M62.27%
Dec 29, 200694.10M31.24%
Dec 30, 200571.70M-0.42%
Dec 31, 200472.00M94.07%
Dec 31, 200337.10M183.21%
Dec 31, 200213.10M-52.88%
Dec 31, 200127.80M-35.94%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 911.75B
Johnson & Johnson 491.33B
AbbVie 407.03B
UnitedHealth Group 302.67B
AstraZeneca 283.29B
Novartis AG 257.47B
Merck & Co. 251.85B
Abbott Laboratories 216.94B
Market Cap Rankings